På grund af muligheden for øget blødningsrisiko bør kombinationen warfarin (eller andre kumarinderivater) og prasugrel administreres med forsigtighed (se pkt 4. 4).
Because of the potential for increased risk of bleeding, warfarin (or other coumarin derivatives) and prasugrel should be co-administered with caution (see section 4.4).